FGF gets in your bones by LeBrasseur, Nicole
 
IN THIS ISSUE • THE JOURNAL OF CELL BIOLOGY 985
 
Text by Nicole LeBrasseur
lebrasn@rockefeller.edu
 
FGF gets in your bones
 
nt-mediated differentiation of bone precursors gets shut down, say
Mansukhani et al. on page 1065, if there is too much FGF receptor
(FGFR) activity.
Bones form through the maturation of osteoblasts. This process is dis-
rupted in the skulls of patients with activating mutations in FGFR1 and FGFR2.
The new evidence suggests that FGF counteracts differentiation by blocking
Wnt. Microarray analysis revealed that, although Wnt-regulated genes are
normally turned on in maturing osteoblasts, their activation is dampened in the
overactive FGFR mutant osteoblasts.
A major mediator of the FGF-induced Wnt down-regulation seems to be the
Sox2 transcription factor. Normally associated with neurons or embryonic stem
cells, Sox2 is now shown to be strongly expressed in osteoblasts when FGF signaling
is high. Sox2 was associated with 
 
 
 
-catenin in osteoblasts and blocked Wnt
W
Sox2 prevents the differentiation of osteoblasts at 
the osteogenic front (of).
 
signaling, possibly by competing with other 
 
 
 
-catenin partners, such as TCF/LEF transcriptional coactivators.
Wnt signals are used in multiple differentiation pathways, including several that are not blocked by
FGF. Perhaps Sox2 is permanently silenced in the unaffected cell types. It will now be important to examine
FGF and Sox2 regulation in normal and pathological skull development. Sox2 was found at osteogenic
fronts in mice crania, where FGFR2 activity is known to be high, and may act as a brake on osteoblast
differentiation. Harmonious bone formation, like other developmental processes, probably results from the
interplay between positive and negative signals. 
 
Binding a bent integrin
 
bent integrin still has room for
its ligand, according to Adair et
al. on page 1109. Integrin acti-
vation by internal signals may therefore
not depend on the protein assuming a more
extended conformation.
To prevent unregulated adhesion,
most integrins are expressed in an inactive
form. EM and crystal structures showed
that the extracellular domain of the inte-
grin 
 
 
 
V
 
 
 
3 without its ligand can assume a
bent conformation. 2D EM reconstruc-
tions of the same domain in the presence
of a small peptide suggested that the
bound form, in contrast, was extended.
These results supported a switchblade
model, in which the binding of cytoplas-
mic signals initiates the movement of sev-
eral intra- and extracellular domains that
opens and activates the integrin by expos-
ing its ligand-binding site.
But Adair et al. suggest that such
large-scale changes may not be neces-
sary. The authors generated 3D EM re-
constructions using a larger, physiological
ligand (in this case, a piece of fibronectin).
Particles to be analyzed were also selected
automatically to minimize bias.
A 
 
The 3D maps
showed that most of the
fibronectin-bound inte-
grin complexes were in a
bent conformation. The
maps with and without
the ligand looked gener-
ally similar. But in the
ligand’s presence, addi-
tional densities consistent
with the size of two fi-
bronectin domains were
found at the ligand-bind-
ing sites.
If, as the findings
indicate, no large-scale
opening is needed to make
room for ligand, then the
mechanism of activation
by intracellular signals
should be revisited. For
instance, a slight sideways
movement of a membrane-proximal ex-
tracellular domain of the 
 
 
 
-subunit away
from the ligand-binding site may be suffi-
cient. This model involves much smaller
conformational changes than does the
switchblade model.
It is possible that the switchblade
movement has quite a different function.
For example, it may be part of the con-
formational changes induced by ligand
binding that culminate in intracellular
responses. 
Fibronectin (green and yellow) can bind to a bent integrin 
(blue and red).
 
1687iti  Page 985  Thursday, March 17, 2005  10:45 AM